Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study, PLOS Med, vol.4, p.21, 2007. ,
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS, AIDS, vol.23, pp.525-530, 2009. ,
Deciphering the model pathogenic fungus Cryptococcus neoformans, Nat Rev Microbiol, vol.3, pp.753-764, 2005. ,
Immunity to fungi, Curr Opin Immunol, vol.18, pp.465-472, 2006. ,
Cryptococcal interactions with the host immune system, Eukaryot Cell, vol.9, pp.835-846, 2010. ,
Dueling in the lung: how Cryptococcus spores race the host for survival, Curr Opin Microbiol, vol.13, pp.437-442, 2010. ,
In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages, J Infect Dis, vol.184, pp.479-487, 2001. ,
Cryptococcus neoformans: intracellular or extracellular?, Trends Microbiol, vol.9, pp.417-418, 2001. ,
An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia, J Immunol, vol.175, pp.3244-3251, 2005. ,
Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice, Infect Immun, vol.75, pp.4792-4798, 2007. ,
Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans, Infect Immun, vol.77, pp.3749-3758, 2009. ,
The capsule of the fungal pathogen Cryptococcus neoformans, Adv Appl Microbiol, vol.68, pp.133-216, 2009. ,
App1: an antiphagocytic protein that binds to complement receptors 3 and 2, J Immunol, vol.182, pp.84-91, 2009. ,
A Major Role for Capsule-Independent Phagocytosis-Inhibitory Mechanisms in Mammalian Infection by Cryptococcus neoformans, Cell Host Microbe, vol.9, pp.243-251, 2011. ,
Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages, Curr Biol, vol.16, pp.2161-2165, 2006. ,
Expulsion of live pathogenic yeast by macrophages, Curr Biol, vol.16, pp.2156-2160, 2006. ,
Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm, Proc Natl Acad Sci U S A, vol.99, pp.3165-3170, 2002. ,
Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice, Infect Immun, vol.67, pp.4469-4476, 1999. ,
Receptor-mediated recognition of Cryptococcus neoformans, Nippon Ishinkin Gakkai Zasshi, vol.43, pp.133-136, 2002. ,
Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans, Infect Immun, vol.73, pp.592-598, 2005. ,
Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8, Cell Microbiol, vol.8, pp.267-275, 2006. ,
Capsular polysaccharide induction of apoptosis by intrinsic and extrinsic mechanisms, Cell Microbiol, vol.10, pp.2129-2137, 2008. ,
Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand, Cell Microbiol, vol.10, pp.1274-1285, 2008. ,
Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway, Int Immunol, vol.20, pp.1527-1541, 2008. ,
Introduction to NF-kappaB: players, pathways, perspectives, Oncogene, vol.25, pp.6680-6684, 2006. ,
NF-kappaB and the immune response, Oncogene, vol.25, pp.6758-6780, 2006. ,
Current insights into the regulation of programmed cell death by NF-kappaB, Oncogene, vol.25, pp.6800-6816, 2006. ,
Shared principles in NF-kappaB signaling, Cell, vol.132, pp.344-362, 2008. ,
IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation, Nature, vol.434, pp.1138-1143, 2005. ,
Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1), Proc Natl Acad Sci U S A, vol.102, pp.12425-12430, 2005. ,
The two NF-kappaB activation pathways and their role in innate and adaptive immunity, Trends Immunol, vol.25, pp.280-288, 2004. ,
Regulation and function of NF-kappaB transcription factors in the immune system, Annu Rev Immunol, vol.27, pp.693-733, 2009. ,
The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development, Biochem Pharmacol, vol.72, pp.1161-1179, 2006. ,
UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis, Eukaryot Cell, vol.3, pp.1601-1608, 2004. ,
Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans, J Immunol, vol.142, pp.659-665, 1989. ,
Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence, Mol Microbiol, vol.64, pp.771-781, 2007. ,
Capsule Structure Changes Associated with Cryptococcus neoformans Crossing of the Blood-Brain Barrier, Am J Pathol, vol.166, pp.421-432, 2005. ,
Nuclear factor (NF)-kappa-B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses, J Exp Med, vol.187, pp.185-196, 1998. ,
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells, Nature, vol.409, pp.355-359, 2001. ,
Mad2 overexpression promotes aneuploidy and tumorigenesis in mice, Cancer Cell, vol.11, pp.9-23, 2007. ,
An antiinflammatory role for IKKbeta through the inhibition of ''classical'' macrophage activation, J Exp Med, vol.205, pp.1269-1276, 2008. ,
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB, Proc Natl Acad Sci U S A, vol.106, pp.14978-14983, 2009. ,
Cell death in the host response to infection, Cell Death Differ, vol.15, pp.1339-1349, 2008. ,
Possible new role for NF-kappaB in the resolution of inflammation, Nat Med, vol.7, pp.1291-1297, 2001. ,
Involvement of glycoreceptors in galactoxylomannan-induced T cell death, J Immunol, vol.182, pp.6003-6010, 2009. ,
Regulation of programmed cell death by NF-kappaB and its role in tumorigenesis and therapy, Adv Exp Med Biol, vol.615, pp.223-250, 2008. ,
A critical role for the RelA subunit of nuclear factor kappa B in regulation of multiple immune-response genes and in Fasinduced cell death, J Exp Med, vol.189, pp.999-1004, 1999. ,
Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle, Trends Microbiol, vol.13, pp.103-110, 2005. ,
HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses, J Clin Invest, vol.108, pp.757-764, 2001. ,
Evidence of mRNA-mediated intron loss in the human-pathogenic fungus Cryptococcus neoformans, Eukaryot Cell, vol.5, pp.789-793, 2006. ,
Fc-and complement-receptor activation stimulates cell cycle progression of macrophage cells from G1 to S, J Immunol, vol.174, pp.7226-7233, 2005. ,
Intracellular cryptococci suppress Fc-mediated cyclin D1 elevation, Commun Integr Biol, vol.3, pp.390-391, 2010. ,
IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival, Proc Natl Acad Sci U S A, vol.100, pp.15800-15805, 2003. ,
A cell cycle regulatory network controlling NF-kappaB subunit activity and function, Embo J, vol.26, pp.4841-4855, 2007. ,
IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1-to S-phase progression, Embo J, vol.25, pp.3801-3812, 2006. ,
NFkappa B function in growth control: Regulation of cyclin D1 expression and G(0)G(1)-to-S-Phase transition, Mol Cell Biol, vol.19, pp.2690-2698, 1999. ,
) c-rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition, Mol Cell Biol, vol.17, pp.6526-6536, 1997. ,
Negatively regulates transcription of the cyclin E gene, J Biol Chem, vol.285, pp.17453-17464, 2010. ,
Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control, J Virol, vol.70, pp.2324-2331, 1996. ,
Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway, J Virol, vol.83, pp.12590-12600, 2009. ,
Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability, J Biol Chem, vol.284, pp.22166-22172, 2009. ,
Mitotic chromosomal instability and cancer: mouse modelling of the human disease, Nat Rev Cancer, vol.10, pp.102-115, 2010. ,
Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice, Int J Cancer, vol.124, pp.1483-1489, 2009. ,